92 related articles for article (PubMed ID: 16814354)
1. Gene expression profiles reveal an upregulation of E2F and downregulation of interferon targets by HPV18 but no changes between keratinocytes with integrated or episomal viral genomes.
Karstensen B; Poppelreuther S; Bonin M; Walter M; Iftner T; Stubenrauch F
Virology; 2006 Sep; 353(1):200-9. PubMed ID: 16814354
[TBL] [Abstract][Full Text] [Related]
2. Type-dependent integration frequency of human papillomavirus genomes in cervical lesions.
Vinokurova S; Wentzensen N; Kraus I; Klaes R; Driesch C; Melsheimer P; Kisseljov F; Dürst M; Schneider A; von Knebel Doeberitz M
Cancer Res; 2008 Jan; 68(1):307-13. PubMed ID: 18172324
[TBL] [Abstract][Full Text] [Related]
3. Interferon-beta treatment of cervical keratinocytes naturally infected with human papillomavirus 16 episomes promotes rapid reduction in episome numbers and emergence of latent integrants.
Herdman MT; Pett MR; Roberts I; Alazawi WO; Teschendorff AE; Zhang XY; Stanley MA; Coleman N
Carcinogenesis; 2006 Nov; 27(11):2341-53. PubMed ID: 16973673
[TBL] [Abstract][Full Text] [Related]
4. Selection of cervical keratinocytes containing integrated HPV16 associates with episome loss and an endogenous antiviral response.
Pett MR; Herdman MT; Palmer RD; Yeo GS; Shivji MK; Stanley MA; Coleman N
Proc Natl Acad Sci U S A; 2006 Mar; 103(10):3822-7. PubMed ID: 16505361
[TBL] [Abstract][Full Text] [Related]
5. Interferon treatment of human keratinocytes harboring extrachromosomal, persistent HPV-16 plasmid genomes induces de novo viral integration.
Lace MJ; Anson JR; Haugen TH; Dierdorff JM; Turek LP
Carcinogenesis; 2015 Jan; 36(1):151-9. PubMed ID: 25416558
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic silencing of interferon-kappa in human papillomavirus type 16-positive cells.
Rincon-Orozco B; Halec G; Rosenberger S; Muschik D; Nindl I; Bachmann A; Ritter TM; Dondog B; Ly R; Bosch FX; Zawatzky R; Rösl F
Cancer Res; 2009 Nov; 69(22):8718-25. PubMed ID: 19887612
[TBL] [Abstract][Full Text] [Related]
7. Progression from productive infection to integration and oncogenic transformation in human papillomavirus type 59-immortalized foreskin keratinocytes.
Spartz H; Lehr E; Zhang B; Roman A; Brown DR
Virology; 2005 May; 336(1):11-25. PubMed ID: 15866067
[TBL] [Abstract][Full Text] [Related]
8. A new E6/P63 pathway, together with a strong E7/E2F mitotic pathway, modulates the transcriptome in cervical cancer cells.
Teissier S; Ben Khalifa Y; Mori M; Pautier P; Desaintes C; Thierry F
J Virol; 2007 Sep; 81(17):9368-76. PubMed ID: 17582001
[TBL] [Abstract][Full Text] [Related]
9. The role of the human papillomavirus type 18 E7 oncoprotein during the complete viral life cycle.
McLaughlin-Drubin ME; Bromberg-White JL; Meyers C
Virology; 2005 Jul; 338(1):61-8. PubMed ID: 15921717
[TBL] [Abstract][Full Text] [Related]
10. Molecular mechanisms of hyperplasia induction by human papillomavirus E7.
Ueno T; Sasaki K; Yoshida S; Kajitani N; Satsuka A; Nakamura H; Sakai H
Oncogene; 2006 Jul; 25(30):4155-64. PubMed ID: 16501608
[TBL] [Abstract][Full Text] [Related]
11. The E6E7 oncoproteins of cutaneous human papillomavirus type 38 interfere with the interferon pathway.
Cordano P; Gillan V; Bratlie S; Bouvard V; Banks L; Tommasino M; Campo MS
Virology; 2008 Aug; 377(2):408-18. PubMed ID: 18519144
[TBL] [Abstract][Full Text] [Related]
12. The human papillomavirus type 18 E6 oncoprotein induces Vascular Endothelial Growth Factor 121 (VEGF121) transcription from the promoter through a p53-independent mechanism.
Clere N; Bermont L; Fauconnet S; Lascombe I; Saunier M; Vettoretti L; Plissonnier ML; Mougin C
Exp Cell Res; 2007 Sep; 313(15):3239-50. PubMed ID: 17678892
[TBL] [Abstract][Full Text] [Related]
13. Silencing of HPV 18 oncoproteins With RNA interference causes growth inhibition of cervical cancer cells.
Lea JS; Sunaga N; Sato M; Kalahasti G; Miller DS; Minna JD; Muller CY
Reprod Sci; 2007 Jan; 14(1):20-8. PubMed ID: 17636212
[TBL] [Abstract][Full Text] [Related]
14. Retrovirus-mediated gene transfer to analyze HPV gene regulation and protein functions in organotypic "raft" cultures.
Banerjee NS; Chow LT; Broker TR
Methods Mol Med; 2005; 119():187-202. PubMed ID: 16353336
[TBL] [Abstract][Full Text] [Related]
15. The Nuclear DNA Sensor IFI16 Acts as a Restriction Factor for Human Papillomavirus Replication through Epigenetic Modifications of the Viral Promoters.
Lo Cigno I; De Andrea M; Borgogna C; Albertini S; Landini MM; Peretti A; Johnson KE; Chandran B; Landolfo S; Gariglio M
J Virol; 2015 Aug; 89(15):7506-20. PubMed ID: 25972554
[TBL] [Abstract][Full Text] [Related]
16. High human papillomavirus oncogene mRNA expression and not viral DNA load is associated with poor prognosis in cervical cancer patients.
de Boer MA; Jordanova ES; Kenter GG; Peters AA; Corver WE; Trimbos JB; Fleuren GJ
Clin Cancer Res; 2007 Jan; 13(1):132-8. PubMed ID: 17200347
[TBL] [Abstract][Full Text] [Related]
17. Identification of human papillomavirus type 16 integration sites in high-grade precancerous cervical lesions.
Matovina M; Sabol I; Grubisić G; Gasperov NM; Grce M
Gynecol Oncol; 2009 Apr; 113(1):120-7. PubMed ID: 19157528
[TBL] [Abstract][Full Text] [Related]
18. HPV16 E6-mediated stabilization of ErbB2 in neoplastic transformation of human cervical keratinocytes.
Narisawa-Saito M; Handa K; Yugawa T; Ohno S; Fujita M; Kiyono T
Oncogene; 2007 May; 26(21):2988-96. PubMed ID: 17146442
[TBL] [Abstract][Full Text] [Related]
19. Functional implication of sequence variation in the long control region and E2 gene among human papillomavirus type 18 variants.
López-Saavedra A; González-Maya L; Ponce-de-León S; García-Carrancá A; Mohar A; Lizano M
Arch Virol; 2009; 154(5):747-54. PubMed ID: 19337781
[TBL] [Abstract][Full Text] [Related]
20. HPV18 Persistence Impairs Basal and DNA Ligand-Mediated IFN-β and IFN-λ
Albertini S; Lo Cigno I; Calati F; De Andrea M; Borgogna C; Dell'Oste V; Landolfo S; Gariglio M
J Immunol; 2018 Mar; 200(6):2076-2089. PubMed ID: 29386255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
